PubMed HealthSearch

PubMed · 8009104

Acute maxillary sinusitis in general practice: a decision problem.

Abstract

OBJECTIVE: This paper describes a qualitative analysis of a decision problem of acute maxillary sinusitis in general practice. The criteria and expected outcomes on which general practitioners (GPs) base their choice of a management strategy are presented. DESIGN: Structured open-ended interviews, all done by the first author, were transcribed, and summarized for each management strategy. These summaries were sent back to the experts for verification. PARTICIPANTS: Eight expert GPs from The Netherlands participated; all had been practising for at least three years, and had conducted postgraduate research into upper respiratory tract infections. RESULTS: There was a high degree of consensus among the eight GPs. While most practitioners generally considered the prevention of complications of therapy more important than the prevention of complications of disease, patients at risk (e.g., the elderly, children, patients with other chronic diseases, and patients in weakened condition) of complications of acute sinusitis (e.g., chronic sinusitis) were considered an exception to this rule, possibly because the complications of sinusitis are more serious than those of its therapy. Major differences between the GPs concerned the timing of decisions (e.g. prescribing antibiotics after 5 or 21 days of complaints while local therapy was used). CONCLUSION: Although this study gives no answer as to which management strategy is optimal, the results served as a basis in the development of the Dutch "Sinusitis in general practice standard". In order further to develop the optimal strategy, in future research, the probabilities and weights attached to the criteria and expected outcomes have to be quantified.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

G H de Bock, J Kievit, J D Mulder. 1994. Acute maxillary sinusitis in general practice: a decision problem.. https://doi.org/10.3109/02813439408997050

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A randomized trial comparing cyclosporine and steroids with cyclosporine, azathioprine, and steroids in cadaveric renal transplantation.

BACKGROUND: In renal transplantation, triple-drug therapy (low-dose cyclosporine [CsA] combined with azathioprine plus steroids) has been replacing double-drug therapy (CsA plus steroids) in clinical practice without much evidence in favor of either therapy. Previous trials comparing the two immunosuppressive regimens gave conflicting results. We attempted to determine whether triple therapy is at least equivalent to double therapy. METHODS: A randomized trial was performed in 250 adult cadaveric renal transplant recipients, comparing double therapy (CsA [10 mg/kg/day] plus prednisone) with triple therapy (CsA [6 mg/kg/day] plus azathioprine plus prednisone). The median follow-up time was 930 days. RESULTS: The incidence of acute rejection episodes refractory to treatment was 11% in double therapy and 4% in triple therapy (relative risk reduction: 64%; 95% confidence interval: 5-100%; P=0.035). Patients in the double therapy group required more intensive antirejection treatment, and their pathologic lesions were more severe. The proportion of patients with acute rejection was similar (double therapy: 45% vs. triple therapy: 40%) as was the incidence of chronic renal dysfunction (double therapy: 17% vs. triple therapy: 15.5%), the 4-year graft survival (double therapy: 71% vs. triple therapy: 83%, P=0.089), and patient survival (double therapy: 94% vs. triple therapy: 93%). In 29 patients (23%), 35 episodes of azathioprine-induced leukopenia were recorded, and in 9 of them azathioprine had to be discontinued. The incidence of other adverse events did not differ between the groups. CONCLUSIONS: Triple therapy caused fewer episodes of refractory acute rejection episodes and was as efficacious and safe as double therapy.

Acute Disease